These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1212563)

  • 21. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV; Paterson IA; Zhu MY; Matte G
    J Neurochem; 1991 Jan; 56(1):213-20. PubMed ID: 1670953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute hydrocephalus upregulates monoamine oxidase mRNA in neonatal rat brain.
    Kuo MF; Wu KD; Wu RM; Tu YK; Wang HS
    Neuroreport; 2004 Aug; 15(12):1975-8. PubMed ID: 15305148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine metabolism in the guinea pig striatum: role of monoamine oxidase A and B.
    Juorio AV; Paterson IA; Zhu MY
    Eur J Pharmacol; 1994 Mar; 254(3):213-20. PubMed ID: 8013556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
    Thiblin I; Finn A; Ross SB; Stenfors C
    Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for different sites of monoamine oxidase and catechol-O-methyltransferase in the striatum.
    Tokunaga K; Ishikawa K
    Brain Res; 1992 Mar; 575(1):164-6. PubMed ID: 1504778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of methionine-enkephalin and D-alanine methionine-enkephalinamide on the concentration of dopamine metabolites in rat striatum.
    Algeri S; Calderini G; Consolazione A; Garattini S
    Eur J Pharmacol; 1977 Sep; 45(2):207-9. PubMed ID: 902691
    [No Abstract]   [Full Text] [Related]  

  • 28. A kinetic analysis of the effects of beta-phenylethylamine on the concentrations of dopamine and its metabolites in the rat striatum.
    Sato S; Tamura A; Kitagawa S; Koshiro A
    J Pharm Sci; 1997 Apr; 86(4):487-96. PubMed ID: 9109054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of beta-endorphin on striatal dopamine metabolism.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):171-4. PubMed ID: 905630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opiate actions on mesocortical dopamine metabolism in the rat.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1986 Nov; 39(21):2033-6. PubMed ID: 3784768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further studies on the sequence of dopamine metabolism in the rat brain.
    Westerink BH
    Eur J Pharmacol; 1979 Jul; 56(4):313-22. PubMed ID: 477727
    [No Abstract]   [Full Text] [Related]  

  • 32. [Age-related changes in the dopaminergic system in rat striatum].
    Budygin EA; Kovalev GI; Gaĭntdinov RR; Kudrin VS; Voronina TA
    Biull Eksp Biol Med; 1993 Mar; 115(3):301-3. PubMed ID: 8054633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of gamma-hydroxybutyrate on mouse striatal tyramine, dopamine and homovanillic acid.
    Juorio AV
    Br J Pharmacol; 1982 Mar; 75(3):447-50. PubMed ID: 7066598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal profile of levels of monoamines and their metabolites in striata of rats implanted with dialysis tubes.
    Reiriz J; Mena MA; Bazán E; Muradás V; Lerma J; Delgado JM; De Yébenes JG
    J Neurochem; 1989 Sep; 53(3):789-92. PubMed ID: 2474632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
    Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal hypothyroidism induces striatal dopaminergic dysfunction.
    Vaccari A; Rossetti ZL; de Montis G; Stefanini E; Martino E; Gessa GL
    Neuroscience; 1990; 35(3):699-706. PubMed ID: 2199846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic characteristics of dopamine, norepinephrine and serotonin metabolism in axonal endings of the rat hypothalamus and striatum during hypoxia: a study using HPLC with electrochemical detection.
    Saligaut C; Chretien P; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):343-9. PubMed ID: 2426539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.